High materiality9/10
Piper Sandler on LB Pharmaceuticals Inc (LBRX): 'Competitor Data Highlight LB-102's Blockbuster Value'
Why it may matterVerify against the original reporting
Bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
LBPharma (LBRX) target $78; current $43.14. Price since signal: -0.07%. Substantial upside implied.
- Target $78; current $43.14; -0.07% since signal; upside implied.
Key facts
- 01
Target: $78
- 02
Posted price: $43.14
- 03
Analyst firm: Piper Sandler
- 04
Analyst: Yasmeen Rahimi
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.